Search - tctmd.com

Displaying 21 - 40 of 90

Sort: Relevancy | Date

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

June 10, 2022

Presentation TVT 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presenter: Rahul Sharma

June 09, 2022

Presentation TVT 2022

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Presenter: Andrea Scotti

June 09, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

Presenter: Marc Allard-Ratick

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

Presentation TVT 2021

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

Presenter: Horst Sievert

July 22, 2021

Presentation TVT 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Presentation TVT 2021

Session 1: Tailoring Mitral Valve Repair: MitraClip G4 Review & Evolution of TEER

Presenter: Paul Mahoney

July 20, 2021

Presentation TVT 2021

TEER Device Evolution: Impact on Technical Success and Complications

Presenter: Anita Asgar

July 20, 2021

Presentation TVT 2021

Case examples and Clinical Outcomes with a Next-Generation Delivery System and Valve Design

Presenter: Lars Sondergaard

July 20, 2021

Presentation TVT 2021

Impact of THV Design to Achieve Supra-Annular Hemodynamics in an Intra-Annular Valve: Benchtop and Clinical Insights

Presenter: Gregory Fontana

July 20, 2021

Presentation TVT 2021

Remaining Unmet Technical and Clinical Needs in TAVR: Opportunities for Innovation to Improve Clinical Outcomes

Presenter: Azeem Latib

July 20, 2021

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

Advertisement

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Proven Safety through MitraClip G4 and Evolution of TEER

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

Complete 2-year Follow-Up from Evolut Low Risk Trial

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Session 1: Tailoring Mitral Valve Repair: MitraClip G4 Review & Evolution of TEER

TEER Device Evolution: Impact on Technical Success and Complications

Case examples and Clinical Outcomes with a Next-Generation Delivery System and Valve Design

Impact of THV Design to Achieve Supra-Annular Hemodynamics in an Intra-Annular Valve: Benchtop and Clinical Insights

Remaining Unmet Technical and Clinical Needs in TAVR: Opportunities for Innovation to Improve Clinical Outcomes

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content